|1.||Lee, A: 1 article (10/2014)|
|2.||Liu, S: 1 article (10/2014)|
|3.||Wang, T: 1 article (10/2014)|
|4.||Jensen, Kevin P: 1 article (03/2014)|
|5.||Gelernter, Joel: 1 article (03/2014)|
|6.||Kranzler, Henry R: 1 article (03/2014)|
|7.||Stein, Murray B: 1 article (03/2014)|
|8.||Frucht, David M: 1 article (03/2008)|
|9.||Xu, Lixin: 1 article (03/2008)|
|10.||Fang, Hui: 1 article (03/2008)|
|1.||Restless Legs Syndrome (Restless Legs)
03/01/2014 - "A predicted miR-330-3p target site SNP (rs41305272) in mitogen-activated protein kinase kinase 5 (MAP2K5) mRNA was in LD (d' = 1.0, r(2) = 0.02) with a reported GWAS-identified variant for restless legs syndrome (RLS), a disorder frequently comorbid with anxiety and depression, possibly because of a shared pathophysiology. "
10/01/2014 - "Here, by screening a retroviral cDNA library of 192 active human kinases, we found that three of them, namely cyclin-dependent kinases regulatory subunit 1 (CKS1B), mitogen-activated protein kinase kinase 5 (MAP2K5) and protein kinase C and casein kinase substrate in neurons 1 (PACSIN1), potently suppressed HCV infection. "
03/15/2008 - "We herein report that anthrax LT binds and enters murine neutrophils, leading to the cleavage of mitogen-activated protein kinase kinase/MEK/MAPKK 1-4 and 6, but not mitogen-activated protein kinase kinase 5 and 7. Anthrax LT treatment of neutrophils disrupts signaling to downstream MAPK targets in response to TLR stimulation. "
|2.||Casein Kinases (Casein Kinase)
|3.||Mitogen-Activated Protein Kinase Kinases (MEKs)
|4.||Cyclin-Dependent Kinases (cdk Proteins)
|5.||Messenger RNA (mRNA)
|6.||Protein Kinases (Protein Kinase)
|7.||Protein Kinase C